Keyphrases
25(OH)D Concentration
25%
25-hydroxyvitamin D (25OHD)
50%
25-hydroxyvitamin D2
50%
25-hydroxyvitamin D3
50%
25OHD2
33%
2nd Trimester
16%
Birth children
16%
Cesarean Section (C-section)
16%
Cotinine
25%
D-dimer
50%
Delivery Period
16%
During Pregnancy
83%
Endothelial Cells
31%
Endothelial Nitric Oxide Synthase (eNOS)
50%
Environmental Tobacco Smoke Exposure
50%
Evacuation
50%
Exposure during Pregnancy
50%
Gestational Age
55%
Gestational Diabetes
16%
Gestational Hypertension
16%
Gynecologic Surgery
25%
Healthy Women
22%
Hepcidin
41%
Hepcidin Levels
50%
High-risk Pregnancy
25%
Infant Birth Weight
50%
Iron Deficiency
50%
Lemierre Syndrome
50%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
16%
Longitudinal Cohort Study
100%
Nitric Oxide Synthase Activity
25%
Non-smokers
31%
Normal Pregnancy
100%
Polycystic Ovary Syndrome
50%
Preeclampsia
16%
Pregnancy Disorders
16%
Pregnancy Period
16%
Pregnant Women
50%
Prospective Cohort Study
50%
Related Disorders
16%
Respiratory Problems
25%
Sampling Season
50%
Serious Complications
25%
Small-for-gestational Age
16%
Smokers
50%
Surgical Intervention
25%
Surgical Procedures
25%
Umbilical Vein
50%
Uterus
50%
Vitamin D
25%
Medicine and Dentistry
25 Hydroxyergocalciferol
50%
25 Hydroxyvitamin D
20%
Biological Variation
5%
Blood Sampling
10%
Calcifediol
50%
Cesarean Section
32%
Childbirth
10%
Cohort Analysis
100%
Complication of Pregnancy
10%
D-Dimer
50%
Disease
16%
Evacuation
50%
First Trimester Pregnancy
10%
Gestational Age
55%
Gestational Diabetes
16%
Gestational Hypertension
16%
Gynecological Surgery
25%
Hepcidin
50%
Iron Deficiency
50%
Iron Metabolism
8%
Large for Gestational Age
16%
Lemierre's Syndrome
50%
Liquid Chromatography-Mass Spectrometry
18%
Polycystic Ovary Syndrome
50%
Pre-Eclampsia
16%
Pregnancy
5%
Premature Labor
16%
Prospective Cohort Study
50%
Puerperium
16%
Small for Gestational Age
16%
Supplementation
16%
Surgery
25%
Surgical Technique
25%
Tandem Mass Spectrometry
10%
Thromboembolism
11%
Vaginal Delivery
5%
Vitamin D
50%
